The IBMS welcomes the publication of the COVID-19 Inquiry’s Module 2 report which examines core decision-making, political governance and public health responses during the pandemic.
The Institute of Biomedical Science (IBMS), the Royal College of Pathologists (RCPath) and the Association for Laboratory Medicine (LabMed) have released a joint statement announcing a temporary pause in national quality assurance panel activities while a sustainable model is developed.
Investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
Following the suspension of a COVID-19 testing laboratory in Wolverhampton, the IBMS publicly reiterates the need for a regulated workforce and laboratory accreditation for mass testing centres.
